Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06080698 · ClinicalTrials.gov registry record · NA
Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial
A NA study of Gram-negative Bacteremia, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 1,030
- Enrollment target
- 11
- Study locations
NCT06080698 is a NA study of Gram-negative Bacteremia that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 1,030 participants. The trial reports 11 study locations across 10 states.
The verdict
NCT06080698, a NA study of Gram-negative Bacteremia, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,030 participants
- Enrollment target
- 11
- Study locations
Study Summary
The Gram-negative bloodstream infection Oral Antibiotic Therapy trial (The GOAT Trial) is a multi-center, randomized clinical trial that hypothesizes that early transition to oral antibiotic therapy for the treatment of Gram-Negative BloodStream Infection (GN-BSI) is as effective but safer than remaining on intravenous (IV) antibiotic therapy for the duration of treatment.
Conditions Studied
Interventions
- DRUG Intravenous Antibiotics
- DRUG Oral Antibiotics
Study Locations (11)
Maryland
- University of Maryland Medical Center - Baltimore
- Johns Hopkins University Hospital Systems - Baltimore
California
- University of California, San Francisco - San Francisco
Colorado
- Denver Health Hospital Authority - Denver
Minnesota
- Mayo Clinic - Rochester
New Jersey
- Rutgers-RWJ University Hospital - New Brunswick
North Carolina
- Duke University - Durham
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,030 participants |
| Start Date | 2024-02-22 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06080698
The ClinicalTrials.gov registry entry for NCT06080698 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,030 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gram-negative Bacteremia appearing as the primary indexed condition, and to 2 interventions - of which Intravenous Antibiotics is the first listed.
NCT06080698 reports 11 study locations spanning 10 distinct geographic areas - top geographies include Maryland, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT06080698 about?
NCT06080698 is a clinical study titled "Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial". The Gram-negative bloodstream infection Oral Antibiotic Therapy trial (The GOAT Trial) is a multi-center, randomized clinical trial that hypothesizes that early transition to oral antibiotic therapy for the treatment of Gram-Negative BloodStream Infection (GN-BSI) is as effective but safer than rema...
What is the current status of trial NCT06080698?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,030 participants. The study started on 2024-02-22. Estimated completion is 2027-06-30.
What conditions does trial NCT06080698 study?
This clinical trial studies the following conditions: Gram-negative Bacteremia.
What interventions are being tested in trial NCT06080698?
The interventions under investigation include: Intravenous Antibiotics (DRUG), Oral Antibiotics (DRUG).
Who is sponsoring clinical trial NCT06080698?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06080698 being conducted?
This trial has 11 study locations across California, Colorado, Maryland, Minnesota, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.